Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative IV Amantadine in Parkinson's Disease
NCT00600093Phase 2Terminated
- Sponsor
- Rabin Medical Center
- Start
- Jan 2008
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amantadine hydrochloride intravenous solution in Parkinson's disease (PD), sponsored by Rabin Medical Center. Started Jan 2008; status: terminated.
02
Drugs
amantadine hydrochloride intravenous solution
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00600093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00600093.